HRTX
Price
$1.95
Change
+$0.05 (+2.63%)
Updated
Sep 18 closing price
54 days until earnings call
LRMR
Price
$6.85
Change
+$0.04 (+0.59%)
Updated
Sep 18 closing price
54 days until earnings call
Ad is loading...

HRTX vs LRMR

Header iconHRTX vs LRMR Comparison
Open Charts HRTX vs LRMRBanner chart's image
Heron Therapeutics
Price$1.95
Change+$0.05 (+2.63%)
Volume$1.8M
CapitalizationN/A
Larimar Therapeutics
Price$6.85
Change+$0.04 (+0.59%)
Volume$503.65K
CapitalizationN/A
View a ticker or compare two or three
HRTX vs LRMR Comparison Chart
Loading...
HRTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
HRTX vs. LRMR commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a Buy and LRMR is a StrongSell.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (HRTX: $1.95 vs. LRMR: $6.85)
Brand notoriety: HRTX and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 81% vs. LRMR: 125%
Market capitalization -- HRTX: $295.75M vs. LRMR: $434.52M
HRTX [@Biotechnology] is valued at $295.75M. LRMR’s [@Biotechnology] market capitalization is $434.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 5 TA indicator(s) are bullish while LRMR’s TA Score has 2 bullish TA indicator(s).

  • HRTX’s TA Score: 5 bullish, 3 bearish.
  • LRMR’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than LRMR.

Price Growth

HRTX (@Biotechnology) experienced а +7.73% price change this week, while LRMR (@Biotechnology) price change was -8.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.99%. For the same industry, the average monthly price growth was +1.54%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

HRTX is expected to report earnings on Nov 12, 2024.

LRMR is expected to report earnings on Nov 12, 2024.

Industries' Descriptions

@Biotechnology (+0.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($435M) has a higher market cap than HRTX($296M). LRMR YTD gains are higher at: 50.549 vs. HRTX (14.706). HRTX has higher annual earnings (EBITDA): -39.7M vs. LRMR (-65.51M). LRMR has more cash in the bank: 226M vs. HRTX (67.3M). LRMR has less debt than HRTX: LRMR (5.6M) vs HRTX (179M). HRTX has higher revenues than LRMR: HRTX (136M) vs LRMR (0).
HRTXLRMRHRTX / LRMR
Capitalization296M435M68%
EBITDA-39.7M-65.51M61%
Gain YTD14.70650.54929%
P/E RatioN/AN/A-
Revenue136M0-
Total Cash67.3M226M30%
Total Debt179M5.6M3,199%
FUNDAMENTALS RATINGS
HRTX vs LRMR: Fundamental Ratings
HRTX
LRMR
OUTLOOK RATING
1..100
2662
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6359
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (31) in the null industry is somewhat better than the same rating for HRTX (71) in the Biotechnology industry. This means that LRMR’s stock grew somewhat faster than HRTX’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to HRTX’s over the last 12 months.

LRMR's SMR Rating (100) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to HRTX’s over the last 12 months.

LRMR's Price Growth Rating (59) in the null industry is in the same range as HRTX (63) in the Biotechnology industry. This means that LRMR’s stock grew similarly to HRTX’s over the last 12 months.

LRMR's P/E Growth Rating (100) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to HRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HRTXLRMR
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
87%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
HRTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSCRX11.63N/A
N/A
Madison Small Cap R6
RYENX238.60-0.25
-0.10%
Rydex Energy A
CFWAX31.15-0.05
-0.16%
Calvert Global Water A
PIREX31.30-0.12
-0.38%
Principal Real Estate Securities Inst
GAUIX6.33-0.04
-0.63%
Gabelli Utilities I

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with AMRN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
+2.63%
AMRN - HRTX
44%
Loosely correlated
+0.32%
RPTX - HRTX
42%
Loosely correlated
+0.91%
CRSP - HRTX
40%
Loosely correlated
-0.64%
EDIT - HRTX
40%
Loosely correlated
+0.26%
BEAM - HRTX
39%
Loosely correlated
-0.27%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+0.59%
SVRA - LRMR
44%
Loosely correlated
+0.23%
ALLO - LRMR
40%
Loosely correlated
N/A
SNDX - LRMR
39%
Loosely correlated
-0.33%
HRTX - LRMR
39%
Loosely correlated
+2.63%
ABUS - LRMR
38%
Loosely correlated
+1.23%
More